Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
What is Agios Pharmaceuticals's quote symbol?
What is the 52 week high and low for Agios Pharmaceuticals (NASDAQ: AGIO)?
How much is Agios Pharmaceuticals stock worth today?
How much is Agios Pharmaceuticals's stock price per share?
What is Agios Pharmaceuticals's Market Cap?